Stay updated on REOLYSIN in KRAS Mutant CRC Clinical Trial
Sign up to get notified when there's something new on the REOLYSIN in KRAS Mutant CRC Clinical Trial page.

Latest updates to the REOLYSIN in KRAS Mutant CRC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedNo significant additions or deletions were detected on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedUpdate includes a funding-related operations notice and a version bump to v3.2.0, replacing the previous v3.1.0.SummaryDifference4%

- Check48 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.2%

- Check70 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.2%

- Check77 days agoChange DetectedThe web page has added significant medical topics related to cancer and immunotherapy, as well as specific compounds and enzymes, while removing various terms related to diseases and agents, including the location details of The Bronx.SummaryDifference9%

Stay in the know with updates to REOLYSIN in KRAS Mutant CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the REOLYSIN in KRAS Mutant CRC Clinical Trial page.